SM

Investor profile

Seamus Mulligan

Operator angel

2known investments

Seamus Mulligan is an operator angel. The known portfolio counts 2 companies: Adapt Pharma and Avectas.

Is Seamus Mulligan a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

LinkedIn profile on fileEmail and phone open on the Raise plan.
Get contact

Seamus Mulligan portfolio companies (2)

  • Adapt Pharma
  • Avectas

Investor Profile

The known portfolio sits in sector Healthcare, and focus areas Biotech, Cell Therapy, MedTech and Pharmaceuticals.

Stage-wise, the known deals cluster around Growth and Series A rounds.

Reviewing the investment history helps decide whether there is a realistic fit before reaching out.

Similar investors

Showing 20 of 100

Frequently asked questions

Who is Seamus Mulligan?

Seamus Mulligan is an operator angel with 2 known investments on file, among them Adapt Pharma and Avectas. The sections above list the sectors and stages attached to that record.

What does Seamus Mulligan invest in?

Listed sectors include Healthcare; listed focus areas include Biotech, Cell Therapy, MedTech and Pharmaceuticals. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.

What stage does Seamus Mulligan invest at?

The known deals of Seamus Mulligan include Growth and Series A rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.

How do I contact Seamus Mulligan?

A LinkedIn page is on file for Seamus Mulligan. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 2 October 2026 · How this data is built · Report a correction or request removal